Search for: "Abbott Laboratories v. Mylan Pharmaceuticals, Inc." Results 1 - 20 of 43
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
17 Mar 2020, 1:32 pm by Noble McIntyre
Eco-Gel 200 ultrasound gel has been recalled by Eco-Med Pharmaceutical, Inc. due to bacterial contamination. [read post]
18 Jul 2014, 11:55 am
Wyeth Pharmaceuticals, Inc., 2008 WL 7136137 (Ala. [read post]
24 Aug 2011, 12:33 am by Marie Louise
Novartis (IPBiz) Simcor (Niacin, Simvastatin) – US: Abbott Laboratories files patent infringement complaint against Teva in response to Para IV challenge (Patent Docs) Vanos (Fluocinonide) – US: Medicis and Nycomed settle Vanos patent dispute (Patent Docs) Viagra (Sildenafil) – US: Pfizer’s patent on Viagra upheld by the EDVA: Pfizer v Teva (Rocket Docket IP Blog) (Patent Docs) (The IP Factor) [read post]
3 Aug 2011, 3:31 am by Marie Louise
Patent and Trademark Office (Orange Book Blog) (IP Watch) (KEI) (Patent Docs) (Patent Docs) (IP Spotlight) (Patently-O) (Inventive Step) (Patentology) (Patent Law Practice Center) (IPBiz) (Out-Law) (PharmaPatents) (Maier & Maier) (Patent Docs) (Patent Baristas) Memantine – EU: CJEU ruling rejects pre-65/65 authorisations: Case C-195/09 Synthon v Merz Pharma (The SPC Blog) (EPLAW) Modafinil – UK: EWHC: Constructing a case for infringing particle-size patents: Cephalon… [read post]
20 Jul 2011, 4:04 am by Marie Louise
: Supreme Court hearing Human Genome Sciences Inc v Eli Lilly and Company (IPKat) Nexium (Esomeprazole) – UK: EWHC: Ranbaxy wins declaration of non-infringement: Ranbaxy v AstraZeneca (IPKat) Olanzapine – Spain: Supreme Court hands down landmark judgment on doctrine of equivalents and TRIPS (Kluwer Patent Blog) OxyContin (Oxycodone) – US: Purdue files patent infringement suit against Sandoz in response to Para IV certification (Patent Docs) Prevacid… [read post]
6 Apr 2011, 12:18 am by Marie Louise
427/09 Generics (UK) Ltd v Synaptech Inc (The SPC Blog) Simcor (Niacin, Simvastatin) – US: Abbott files patent infringement complaint against Watson following Para IV certification filing (Patent Docs) Thalomid (Thalidomide) – US: Decision in Lannett Thalomid bioequivalence study sample antitrust lawsuit could reignite debate on generic drug availability and REMS restrictions (FDA Law Blog) Yasmin (Drospirenone, Ethinylestradiol) – UK: Bayer Yasmin… [read post]
8 Dec 2010, 2:20 am by Marie Louise
(America-Israel Patent Law) Ziagen (Abacavir) – US: Mylan’s Matrix receives tentative FDA approval under PEPFAR for Abacavir Sulfate tablets, 60 mg (SmartBrief) [read post]